Weaver Consulting Group - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weaver Consulting Group ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$7,000
-46.2%
402
-27.2%
0.00%
-50.0%
Q2 2020$13,000
+30.0%
5520.0%0.01%
+14.3%
Q1 2020$10,0000.0%5520.0%0.01%
+40.0%
Q4 2019$10,000
-37.5%
5520.0%0.01%
-37.5%
Q3 2019$16,000
+60.0%
552
+99.3%
0.01%
+60.0%
Q2 2019$10,000
+11.1%
2770.0%0.01%
+66.7%
Q1 2019$9,0002770.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders